Form 8-K - Current report:
SEC Accession No. 0001193125-05-204066
Filing Date
2005-10-19
Accepted
2005-10-19 16:22:56
Documents
3
Period of Report
2005-10-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 10/19/2005 d8k.htm 8-K 16292
2 PRESS RELEASE dex99.htm EX-99 93312
3 GRAPHIC g18563gex991x1x1.jpg GRAPHIC 7966
  Complete submission text file 0001193125-05-204066.txt   122516
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: 8-K | Act: 34 | File No.: 000-04829 | Film No.: 051145325
SIC: 2836 Biological Products, (No Diagnostic Substances)